Who invested in VRG Therapeutics

2 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AIBiotech

Follow VRG Therapeutics and see its new rounds in your feed. Start following

Funding summaryUpdated 15 Nov 2026

$21Mraised across 2 rounds since 2023, from 2 sources

$5.5MSeries A$15MSeries B

Latest round: Series B, $15MFeb 2024
Step-upi: 2.7×
Investors: 0

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2024

$5.5MSeries A$15MSeries B

First round: Series A, $5.5M
Biggest round: $15M
Between rounds: 7 months

The rounds

Feb 2024
Series B$15M
No investor was named in the report.
Reported by Firms' own news pages
Aug 2023
Series A$5.5M
No investor was named in the report.
Source recorded

Founders and team

From VRG Therapeutics's own website: 12 on the team.

Lakatos LeventeChief Financial and Operating Officer
Sándor FarkasChief Financial and Operating Officer
Dr.Király BenceGeneral Counsel - Head of Legal
Attila HorváthScientific Project Manager
Bence CsapóJunior Data Scientist
Bánk KozmaBusiness Analyst
Csilla KovácsOffice Manager
Irena AdkinsDirector of Research and Intellectual Property
János KővágóMember of the Board
Márton A. SimonProject Manager
Natalia NovacMember of the Board
Tamás KitkaDirector of Biologics Development

Also claim to have backed them

This firm lists VRG Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.